You are here

Home

CANGET BIOTEKPHARMA, LLC

Company Information
Address
102 SURREY RUN
BUFFALO, NY 14221-4548
United States


http://www.canget-biotek.com
Information

UEI: TJ1JCE59GKX3

# of Employees: 6
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 3

  1. A novel small molecule FL7N-1 for treating pediatric cancer retinoblastoma

    Amount: $224,919.00

    Project Summary Abstract This is an SBIR Phase I proposal to test the feasibility of using a novel small molecule drug for the treatment of a pediatric rare cancerretinoblastomaRbRb is currently treat ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health

  2. A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer

    Amount: $2,101,381.00

    Abstract The goal of this fast track SBIR proposal is to file an investigational new drugINDapplication for testing a novel anticancer drugFLthat is designed to overcome inherent and acquired treatmen ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health

  3. A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer

    Amount: $224,988.00

    Abstract The goal of this fast-track SBIR proposal is to file an investigational new drug (IND) application for testing a novel anticancer drug (FL118) that is designed to overcome inherent and acquir ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government